Once diagnosed, individuals with FH can betreated with lifestyle measures, lipid-lowering therapies,and possibly novel therapies including PCSK9 monoclonalantibodies, anti-sense oligonucleotides targeting APOB andmicrosomal triglyceride transfer protein inhibitors to changethe clinical course of the disease (22). Here, PCSK9 is linked to familial hyperaldosteronism.